Latest News about MRK
Recent news which mentions MRK
3 Long-Term Winners from Charles Schwab’s Top Picks
February 27, 2024
From InvestorPlace
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
From Benzinga
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
February 26, 2024
From InvestorPlace
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
From InvestorPlace
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
From Benzinga
2 Monster Stocks to Buy Without Any Hesitation
February 22, 2024
From Motley Fool
Recession's Shadow Casts Doubt On Soft Landing: Safeguard Your Portfolio With These Stocks
February 16, 2024
From Benzinga
3 Inflation-Proof Stock Picks Following Tuesday’s CPI Report
February 15, 2024
From InvestorPlace
Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals
February 14, 2024
From Benzinga
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
From Benzinga
2 Value Stocks With Monster Yields
February 12, 2024
From Motley Fool
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
From Benzinga
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
February 08, 2024
From Motley Fool
From Benzinga
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
From InvestorPlace
Elanco Animal Health To Offload Aqua Business For $1.3B, Plans To Lower Debt Burden
February 05, 2024
From Benzinga
7 Mutual Funds That Will Outperform in Any Market
February 03, 2024
From InvestorPlace
3 Pharma Stocks to Sell in February Before They Crash and Burn
February 02, 2024
From InvestorPlace
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
From Benzinga
Investor Optimism Improves Following Earnings, Economic Reports; Dow Jumps Over 350 Points
February 02, 2024
From Benzinga
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
From Benzinga
Stocks Recoup Post-Fed Losses As Traders Challenge Powell, Regional Banks Crack, Gold Rises: What's Driving Markets Thursday?
February 01, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.